← back to search

Mathias Luderer

Goethe University Frankfurt · DE
Area of research
Psychiatry and Mental health · Epidemiology
Research interest
Research interests include Attention Deficit Hyperactivity Disorder, Substance Abuse Treatment and Outcomes, Neuroethics, Human Enhancement, Biomedical Innovations, and Neurotransmitter Receptor Influence on Behavior.
h-index
13
citations
721
works
56
NIH funding
primary concept
email

Recent publications

Drinking alcohol to cope with hyperactive ADHD? Self-reports vs. continuous performance test in patients with ADHD and/or alcohol use disorder
Frontiers in Psychiatry 2023cited by 3position: firstdoi
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study
BMC Psychiatry 2022cited by 16position: middledoi
Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch
2022cited by 0position: middledoi
Alcohol use disorders and ADHD
Neuroscience & Biobehavioral Reviews 2021cited by 98position: firstdoi
Stop What You're Doing!—An fMRI Study on Comparisons of Neural Subprocesses of Response Inhibition in ADHD and Alcohol Use Disorder
Frontiers in Psychiatry 2021cited by 8position: middledoi
Validation of the German Version of the Mind Excessively Wandering Scale (MEWS-G)
Fortschritte der Neurologie · Psychiatrie 2021cited by 5position: middledoi
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
European Addiction Research 2020cited by 50position: middledoi
Interaction between behavioral inhibition and neural alcohol cue-reactivity in ADHD and alcohol use disorder
Psychopharmacology 2020cited by 23position: middledoi
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder
European Addiction Research 2018cited by 175position: middledoi
Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks
Scientific Reports 2018cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Esther Sobanski · Johannes Gutenberg University Mainz4 papers (2020–2023)Sabine Vollstädt‐Klein · University Hospital Heidelberg4 papers (2020–2023)Sarah Gerhardt · University Hospital Heidelberg3 papers (2020–2023)Falk Kiefer · Tehran University of Medical Sciences3 papers (2018–2021)Johanna Seidt · University Hospital Heidelberg2 papers (2020–2023)Barbara Alm · University Hospital Heidelberg2 papers (2020–2021)Andreas Reif · Department of Physiological Sciences2 papers (2021–2023)Frances R. Levin · Columbia University1 papers (2018–2018)Sabine Hoffmann · University Hospital Heidelberg1 papers (2023–2023)Alicia Strosche · University Hospital Heidelberg1 papers (2020–2020)Ulrich Schmitt · Johannes Gutenberg University Mainz1 papers (2018–2018)Sven Reinhardt · Johannes Gutenberg University Mainz1 papers (2018–2018) · 1 papers (2021–2021)R Nuriyeva · University Hospital Heidelberg1 papers (2020–2020)Philip Asherson · King's College - North Carolina1 papers (2021–2021)Josep Antoni Ramos‐Quiroga · University Hospital Frankfurt1 papers (2021–2021)Alethea Rachel Xi Ern Lee · University Hospital Heidelberg1 papers (2020–2020)Nicole Fischer · University of Pittsburgh1 papers (2021–2021)Derik Hermann · University Hospital Heidelberg1 papers (2020–2020)Arnt Schellekens · Inholland University of Applied Sciences1 papers (2018–2018)